Connect

Dechert attorneys maintain three active blogs—one focused on the field of biologics, another discussing the financial crisis and a third that covers drug and medical device product liability.

Also, please visit us on Facebook, LinkedIn and on Twitter at @dechertllp, where you can connect with our lawyers and obtain information about our firm.

Biolawgics monitors the significant legislative, regulatory and judicial developments affecting biologics - drugs produced in living organisms that comprise one of the fastest growing segments of the pharmaceutical business. Dechert partners Ann M. Caviani Pease, Ph.D, George G. Gordon, Joshua H. Rawson, Daniel M. Becker, M.D., Robert D. Rhoad, Jonathan D.J. Loeb, Ph.D and Muna Abu-Shaar, Ph.D. serve as primary writers for the blog, which examines both recent major changes and potential future developments in the business and legal environments for this growing industry.

Crunched Credit, with Richard Jones leading a team of bloggers, provides critical and insightful commentary on the ongoing dysfunction of the credit markets and the commercial real estate meltdown. The blog takes a critical look at the commercial real estate capital markets, focuses on legislative and regulatory activity, changes in the law, noteworthy market events and market innovation in these troubled times. We identify trends and note innovative industry responses to the ongoing crisis.

Drug and Device Law is recognized as one of the most widely read product liability blogs on the Internet and has received accolades from LexisNexis and the ABA. It offers a personal take on various topics that arise in the defense of pharmaceutical and medical device product liability litigation. The blog also features breaking news, analysis of legal issues and regularly updated scorecards and "cheat sheets" on a variety of important issues the field. It is co-authored by Dechert's John Sullivan and Michelle Hart Yeary along with lawyers at Reed Smith.